Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany. Real-world evidence from Germany

Winfried März, Franz-Werner Dippel, Karlheinz Theobald, Katherine Gorcyca, Serban R Iorga, David Ansell

Research output: Contribution to journal › Article › peer-review

24 Citations (Scopus)
201 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany. Real-world evidence from Germany'. Together they form a unique fingerprint.

Medicine & Life Sciences